Rheumatology 2000; 39: 1269-1271
© 2000 British Society for Rheumatology
Clinical and laboratory features of scleroderma patients with pulmonary hypertension
Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan
Objective. Pulmonary hypertension (PH) is a frequent cause of death in patients with systemic sclerosis (SSc). In this study, we examined the occurrence of PH and investigated the clinical and laboratory features of SSc patients with PH.
Methods. A cross-sectional study of 125 Japanese patients with SSc was conducted using Doppler echocardiography, other multiple cardiopulmonary tests, and laboratory examination.
Results. PH (systolic pressure >40 mmHg) was diagnosed in 20 patients (16%) by Doppler echocardiography. In the six patients who had secondary pulmonary hypertension (SPH), PH was due to severe pulmonary fibrosis; 14 patients had isolated pulmonary hypertension (IPH). An elevated erythrocyte sedimentation rate (ESR) and increased immunoglobulin G (IgG) were found in a significantly greater proportion of the patients with PH than in those without PH. The incidence of pitting scars/ulcers was significantly greater in the patients with SPH than in those without PH.
Conclusion. Elevated ESR and increased IgG were common features of scleroderma patients with PH, and scleroderma patients with SPH were inclined to have pitting scars/ulcers.
KEY WORDS: Pulmonary hypertension, Scleroderma, Doppler echocardiography.
Correspondence to: H. Ihn, Department of Dermatology, Faculty of Medicine, University of Tokyo, 73-1 Hongo, Bunkyo-ku, Tokyo 1138655, Japan.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Hesselstrand, R. Ekman, J. Eskilsson, A. Isaksson, A. Scheja, A.-K. Ohlin, and A. Akesson Screening for pulmonary hypertension in systemic sclerosis: the longitudinal development of tricuspid gradient in 227 consecutive patients, 1992-2001 Rheumatology, March 1, 2005; 44(3): 366 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Kawut, D. B. Taichman, C. L. Archer-Chicko, H. I. Palevsky, and S. E. Kimmel Hemodynamics and Survival in Patients With Pulmonary Arterial Hypertension Related to Systemic Sclerosis Chest, February 1, 2003; 123(2): 344 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jinnin, H. Ihn, K. Yamane, Y. Asano, N. Yazawa, and K. Tamaki Plasma plasmin-{alpha}2-plasmin inhibitor complex levels are increased in systemic sclerosis patients with pulmonary hypertension Rheumatology, February 1, 2003; 42(2): 240 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.M. Hoeper Pulmonary hypertension in collagen vascular disease Eur. Respir. J., March 1, 2002; 19(3): 571 - 576. [Abstract] [Full Text] [PDF] |
||||


